HIV-1 p17 Antikörper (N-Term)
Kurzübersicht für HIV-1 p17 Antikörper (N-Term) (ABIN1042608)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Recognsies bacterial HIV1 P17 Gag protein
-
Kreuzreaktivität (Details)
- Reacts with HIV1
-
Aufreinigung
- Protein G purified
-
Immunogen
- Bacterially expressed, hexahistidine amino-terminal tagged HIV-1 p17 Gag protein (clade B, HXB-3 isolate).
-
Isotyp
- IgG2b kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Myeloma, fusion partners: SP2/0
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Purified antibody containing PBS 0.1 % sodium azide,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
-
: "HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import." in: The EMBO journal, Vol. 16, Issue 15, pp. 4531-9, (1997) (PubMed).
-
: "HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import." in: The EMBO journal, Vol. 16, Issue 15, pp. 4531-9, (1997) (PubMed).
-
- HIV-1 p17 (Human Immunodeficiency Virus 1 Matrix (HIV-1 p17))
-
Andere Bezeichnung
- HIV1 p17
-
Substanzklasse
- Viral Protein
-
Hintergrund
-
Synonyms:
HIV 1 matrix protein p17 antibody,HIV 1 p17 antibody,HIV1 matrix protein p17 antibody,HIV1 p17antibody,Human immunodeficiency virus 1 matrix protein p17 antibody,Human immunodeficiency virus 1 p17antibody,Human immunodeficiency virus type 1 matrix protein p17 antibody,Human immunodeficiency virus type 1 p17antibody,MA antibody,Matrix protein p17 antibody
Target
-